AmplifyBio | WebDisclosure

BRIEF

published on 07/30/2024 at 13:05, 4 months 22 days ago

AmplifyBio Partners with Lipid Nanoparticle Expert to Enhance Drug Delivery

AmplifyBio MRNA Therapeutics Drug Delivery Lipid Nanoparticles Stephen Burgess
BRIEF

published on 07/30/2024 at 13:05, 4 months 22 days ago

AmplifyBio s'associe à un expert en nanoparticules lipidiques pour améliorer l'administration de médicaments

L'administration De Médicaments AmplifierBio Thérapie À Base D'ARNm Stephen Burgess Nanoparticules Lipidiques
PRESS RELEASE

published on 07/30/2024 at 13:00, 4 months 22 days ago

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
AmplifyBio partners with Stephen Burgess, Ph.D., bringing expertise in LNP formulations for efficient mRNA delivery. Collaboration enhances lipid-based technologies for mRNA therapeutics

AmplifyBio Lipid Nanoparticles Stephen Burgess LNP Formulations MRNA Delivery
BRIEF

published on 04/16/2024 at 13:05, 8 months 5 days ago

AmplifyBio and RNAV8 Bio Form Strategic Partnership for mRNA Therapeutic Development

Strategic Partnership AmplifyBio MRNA Therapeutics RNAV8 Bio GMP Manufacturing
BRIEF

published on 04/16/2024 at 13:05, 8 months 5 days ago

AmplifyBio et RNAV8 Bio forment un partenariat stratégique pour le développement thérapeutique de l'ARNm

Partenariat Stratégique AmplifierBio Biographie De La RNAV8 Thérapie À Base D'ARNm Fabrication BPF
PRESS RELEASE

published on 04/16/2024 at 13:00, 8 months 5 days ago

AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture
AmplifyBio and RNAV8 Bio partner to offer one-stop shop for mRNA therapeutics development, integrating design, optimization, and manufacturing capabilities

Development AmplifyBio MRNA Therapeutics RNAV8 Bio Partnering
PRESS RELEASE

published on 02/08/2024 at 13:00, 10 months 13 days ago

AmplifyBio CEO J. Kelly Ganjei Discusses Solutions for Reducing Costs and Risk in Advanced Therapy Manufacturing During Fireside Chat at Advanced Therapies Week
J. Kelly Ganjei, CEO of AmplifyBio, shared insights at Advanced Therapies Week on the evolution of manufacturing strategies and fundraising in cell and gene therapy development. The fireside chat panel discussed early commercialization, tech transfer, and AmplifyBio's hybrid outsourcing model

AmplifyBio Advanced Therapies Week Cell And Gene Therapy Manufacturing Strategies Hybrid Outsourcing Model
PRESS RELEASE

published on 02/01/2024 at 13:00, 10 months 20 days ago

AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio
AmplifyBio celebrates successful grand opening of AMEC, showcasing manufacturing suites and operating models for advanced therapies. Executives and key speakers highlight the milestone event's significance

AmplifyBio AMEC Manufacturing Suites Advanced Therapies Milestone Event
PRESS RELEASE

published on 11/28/2023 at 13:00, 1 year ago

AmplifyBio Expands Its Vision: Launches Advanced Therapy Manufacturing Enablement Center in New Albany, Ohio
PRESS RELEASE

published on 11/07/2023 at 13:00, 1 year 1 month ago

AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity

Published on 12/21/2024 at 01:30, 14 hours 2 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 2 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 27 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 32 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 2 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 40 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 46 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 21 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 35 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 31 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 14 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 14 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 32 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 32 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 37 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News